AbbVie Profile

<div class='circular--portrait' style='background:#CD0D74;color: white;font-size:3em;padding-top: 25px;;'>ABB</div>

Performance

12 / 100

Odds of Distress

Analyze Filter   Earning Report: February 7, 2020
Equity ratings for AbbVie are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting October 24, 2019 and ending today January 22, 2020. Click here to learn more.

AbbVie Profile

Upcoming quarterly earning report is expected on February 7, 2020. AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. AbbVie operates under Drug ManufacturersGeneral classification in USA and is traded on BATS Exchange. It employs 30000 people. more on AbbVie
AbbVie Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
AbbVie SEC Filings
AbbVie SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameAbbVie
ChairmanRichard GonzalezView All
Thematic Classifications
Active investing themes AbbVie currently participates. An investing theme is an unweighted collection of funds, stocks, ETFs or cryptocurrencies
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering AbbVie.
Piotroski F Score
Academic score to determine the current strength of AbbVie financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Financial Strength
AbbVie ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Long Term Debt to Equity
Debt to Equity Ratio
Return on Investment
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Average Bond Rating: AStrong
Profitability
Few selected profitability drivers of AbbVie representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
Net Income Per Employee
Operating Margin
EBITDA Margin
Gross Margin
Profit Margin
AbbVie (ABBV) is traded on BATS Exchange in USA. It is located in 1 North Waukegan Road, North Chicago, IL 60064-6400, United States and employs 30,000 people. AbbVie is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with current market capitalization of 121.25 B. AbbVie conducts business under Healthcare sector and is part of Drug Manufacturers?General industry. The entity has 1.48 B outstanding shares of which 71.95 M shares are presently shorted by private and institutional investors with about 10.64 trading days to cover. AbbVie Inc. Commo currently holds about 5.42 B in cash with 9.81 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.66.
Check AbbVie Probability Of Bankruptcy

Ownership Allocation (%)

AbbVie Target Price Odds Analysis

Odds Below 87.99HorizonTargetOdds Above 87.99
69.33%30 days 87.99 30.46%
Based on normal probability distribution, the odds of AbbVie to move above current price in 30 days from now is about 30.46 (This AbbVie probability density function shows the probability of AbbVie Stock to fall within a particular range of prices over 30 days) .

AbbVie Top Holders

AbbVie Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Pggm InvestmentsCommon Shares1.2 M103.2 M
Artemis Investment Management LlpCommon SharesM92 M
Clear Street Markets LlcPut Options2.3 K20.4 M
View AbbVie Diagnostics

AbbVie Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

AbbVie Against Markets

Did you try this?

Run Correlation Analysis Now

   

Correlation Analysis

Reduce portfolio risk simply by holding instruments which are not perfectly correlated
All  Next Launch Module

AbbVie Upcoming and Recent Events

AbbVie Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportFebruary 7, 2020
Next Earnings ReportApril 23, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndFebruary 7, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

AbbVie Corporate Filings

AbbVie SEC Reporting

Financial Statements and Exhibits. Other Events
Unclassified Corporate Event
Submission of Matters to a Vote of Security Holders
Results of Operations and Financial Condition

AbbVie Distributions to stockholders

AbbVie Corporate Directors

Frederick Waddell Independent Director
Robert Alpern Independent Director
Glenn Tilton Independent Director
Please continue to Trending Equities. Please also try CEO Directory module to screen ceos from public companies around the world.
Company logos by clearbit